AlgaeNet4AV - Exploring microalgae diversity for the development of novel antiviral compounds
(Marie Skłodowska-Curie Actions MSCA) This project seeks to exploit the microalgae biodiversity, as a source for high-added-value lectins and polyphenols with antiviral properties against influenza and coronavirus pandemic strains. Microalgae derived-compounds are easily amendable, bio-degradable, non-toxic and safe; thus, they are preferred to be used for the development of novel bio-based materials and cosmetics with antiviral potential. Lectins and polyphenols could be highly demanded non-drug interventions across the materials and cosmetics industry as a solution to reduce the risk and speed of contamination and transmission during pandemic outbreaks.
The project will combine the whole value chain in order to:
- develop transcriptomics and metabolomics resources from microalgae diversity as a valuable source for the discovery novel lectins and polyphenols;
- characterize their spectrum of bioactivity and toxicity and provide structure-function relationships;
- develop and optimize application-based microalgae culture systems and downstream processing strategies for higher production rate of the desired compounds;
- develop, formulate and evaluate lectins and polyphenols-based final cosmetics products.
The work will be supported by market assessment, integral biorefinery designs, techno-economic and sustainability assessment. Integrated value chains will be demonstrated to deliver proof-of-concept and demonstrate economic feasibility.
Start Date
01/01/2023End Date
31/12/2026Funded by
HORIZON.1.2 - Marie Skłodowska-Curie Actions (MSCA)Grant agreement ID
Grant agreement ID: 101086437Total cost
- total funding
- 772.800,00 Euro
- FEM funding
- 50.600,00 Euro
Coordinated by
ETHNIKO KENTRO EREVNAS KAI TECHNOLOGIKIS ANAPTYXIS - Grecia
Participants
Project description
(Marie Skłodowska-Curie Actions MSCA) This project seeks to exploit the microalgae biodiversity, as a source for high-added-value lectins and polyphenols with antiviral properties against influenza and coronavirus pandemic strains. Microalgae derived-compounds are easily amendable, bio-degradable, non-toxic and safe; thus, they are preferred to be used for the development of novel bio-based materials and cosmetics with antiviral potential. Lectins and polyphenols could be highly demanded non-drug interventions across the materials and cosmetics industry as a solution to reduce the risk and speed of contamination and transmission during pandemic outbreaks.
The project will combine the whole value chain in order to:
- develop transcriptomics and metabolomics resources from microalgae diversity as a valuable source for the discovery novel lectins and polyphenols;
- characterize their spectrum of bioactivity and toxicity and provide structure-function relationships;
- develop and optimize application-based microalgae culture systems and downstream processing strategies for higher production rate of the desired compounds;
- develop, formulate and evaluate lectins and polyphenols-based final cosmetics products.
The work will be supported by market assessment, integral biorefinery designs, techno-economic and sustainability assessment. Integrated value chains will be demonstrated to deliver proof-of-concept and demonstrate economic feasibility.
Extended description
AlgaeNet4AV is an industry-academia R&D and innovation project with a multidisciplinary approach aimed at generating robust business cases through technology development.
The consortium composed by 11 partners, with 7 European and 2 third-country (USA & Japan) prominent research organisations. Strong industrial leadership is guaranteed through the participation of 5 SMEs.
The projects goals will be achieved through a sustainable way helping meet the increasing demand while creating a positive environmental impact through reduction of carbon emissions.
FEM Project contact person
Official project website
Funding Scheme
Europeo
Loghi
